NEW YORK, Sept. 23, 2019 /PRNewswire/ — Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Arotech Corporation (NASDAQ: ARTX) on behalf of Arotech shareholders concerning the proposed merger with an affiliate of Greenbriar Equity Group, L.P.
Click here to participate in the action.
Pursuant to the proposed transaction, announced on September 23, 2019 and valued at $80.3 million, Arotech shareholders will receive $3 in cash for each share of Arotech common stock owned. The investigation focuses on whether Arotech and its board of directors violated the federal securities laws and/or breached their fiduciary duties to the Company’s shareholders by failing to conduct a fair process and whether and by how much the proposed transaction undervalues the Company.
If you own Arotech shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Alexandra Raymond by email at email@example.com, or by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information concerning our investigation of Arotech please go to https://bespc.com/artx/. For additional information about Bragar Eagel & Squire, P.C. please go to www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
SOURCE Bragar Eagel & Squire, P.C.